-
In the Moment- Winter 2012/2013
Julia Wiley, Tony Handler, Michael B. Lawing, Lori Petitti
-
Yesterday & Today
A Leading LadyBetty Ford's candor about her breast cancer diagnosis helped bring a private issue out of the shadows.
by Corinna Wu
-
In the Moment- Fall 2012
Pamela Clark, Emily-Kate Niskey, Loretta Cox, Tim Buckland
-
Survivor Profile
Touched by an AngelJonny Imerman is the heart and hub of a network of cancer survivors.
by Pamela Ferdinand
-
Yesterday & Today
A Touch of MagicElizabeth Montgomery led a bewitching life that was cut short by colorectal cancer in 1995.
by Sue Rochman
-
Survivor Profile
Spreading the WordAn African-American banking pioneer finds fulfillment in increasing prostate cancer awareness.
by Yvonne Lee
-
In the Moment- Summer 2012
Evelyn Reyes, Sarah Dees, Greg Cantwell, Patrick Gavin.
-
The Survival Gap
In the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
Yesterday & Today
Alec Guinness, Reluctant Intergalactic IconLiver cancer took the legendary actor and his wife of 62 years just months apart. Twelve years later, where do efforts to prevent and treat the disease stand?
by Jocelyn Selim
-
In the Moment- Spring 2012
Todd Spurrier, Barry Haigis, Marianthy Karantzes, Rebecca Casciato
Cancer Talk
Lessons Learned as a Caregiver and Patient
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons